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When	should	travelers		
begin	malaria	prophylaxis?
Travelers should start on chloroquine 
1 to 2 weeks before entering an area 
without chloroquine resistance (strength 
of recommendation [sor]: c, based on 
expert opinion). In areas with chloroquine-
resistant Plasmodium falciparum, travelers 
will need to take atovaquone/proguanil, 
doxycycline, or primaquine 1 day before 
entering the area, or mefloquine 2 to 7 
weeks before travel (sor: B, based on 
prospective patient-oriented outcomes 
and expert opinion).
 before prescribing medications, 
determine malaria risk and sensitivity 
of Plasmodium species by country at 
wwwn.cdc.gov/travel/yellowbookCh5-
malariaYellowFeverTable.aspx (sor: c, 
based on patient-oriented expert opinion).
5 tips to help travelers avoid malaria
Despite our best efforts, more than 10,000 
American and european travelers contract 
malaria each year. Five clinical pointers are 
helpful in prescribing malaria prophylaxis 
and preventing malaria in travelers.
 1. advise patients that they’ll need 
to get their antimalarials before they 
leave for their trip. The CDC recommends 
against the purchase of antimalarials while 
overseas because of concerns about 
product quality. 
 2. encourage patients to plan ahead. 
most local community pharmacies do not 
routinely stock antimalarials and must 
special order them. If a patient mentions 
an upcoming trip, advise them that they’ll 
need to allow an extra 2 weeks to obtain 
their medications. 
 3. consult 1 of 2 continuously 
updated Web sites prior to selecting a 
medication for malaria prophylaxis:  
wwwn.cdc.gov/travel/destinationlist.aspx 
or www.who.int/ith/en. 
 start times vary from 1 day to 
several weeks prior to travel based on the 
medication selected.
 4. encourage patients to spray 
clothing with permethrin prior to travel. 
Permethrin remains effective as a repellent 
even after months of clothing use and 
multiple washes. 
 5. encourage travelers to finish their 
medication after they return and to report 
unexplained fevers for up to 1 year after 
travel. 
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z	 Evidence	summary
Travelers to malaria-endemic areas 
should avoid mosquito bites by using 
netting and repellents, and use chemo-
prophylaxis to prevent infection. 
Although no drug regimen guar-
antees protection against malaria, phy-
sicians should prescribe 1 of several 
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options based on the location of travel, 
the susceptibility of indigenous P falci-
parum, and the side-effect profile.1 
Timing	and	dosage	
of	prophylactic	drugs
Prophylactic medications must be start-
ed at different times before travel, but 
for some medications the optimal time 
to initiate treatment is unclear. Evi-
dence-based recommendations2,3 with 
consideration for side-effect profiles are 
given in the TablE.
In contrast to the pretreatment 
times for all other malarial prophylax-
es, the generally accepted pretreatment 
time for mefloquine is 1 to 2 weeks be-
fore entering a risk area. However, this 
may still be inadequate due to the drug’s 
long half-life, which results in a long 
delay in reaching therapeutic blood lev-
els.4 The evidence indicates that meflo-
quine should be started at least 2, and 
as many as 7, weeks before travel.
The standard recommended dose of 
250 mg/week of mefloquine “produces 
maximum steady-state plasma concen-
trations of 1000 to 2000 mcg/L, which 
are reached only after 7 to 10 weeks.”4 
One study of 293 children under the age 
of 5 years in Malawi found that plasma 
concentrations of mefloquine were be-
low prophylactic level (500 mcg/mL) 
against P falciparum until the fourth 
to seventh week of once-weekly dosing 
(P<.0003).5 
One way of reaching prophylactic 
levels earlier would be to give meflo-
quine 250 mg daily for 3 days followed 
by 250 mg weekly.4 A safety study of 
157 healthy US Marine volunteers 
showed that preloading achieves pro-
phylactic blood levels of mefloquine 
by the third day while weekly me-
floquine is subprophylactic until the 
fifth week.4 
While a study of the long-term use 
of mefloquine in 421 healthy Peace 
Corps volunteers has shown it to be 
safe,6 clinical trials and case reports in-
dicate that a loading dose of mefloquine 
is associated with adverse drug events, 
which include neuropsychiatric and 
gastrointestinal symptoms.4,7
Evidence-based	recommendations	for	prevention	of	malaria2–3,8
Drug usage aDulT Dose TreaTmenT scheDule
atovaquone/ Prophylaxis in areas  1 tablet orally each day  Daily from 1 day prior to entry 
proguanil with chloroquine-resistant or  (250 mg atovaquone and  until 7 days after leaving 
Contraindicated  mefloquine-resistant P falciparum 100 mg proguanil  
in pregnancy  hydrochloride)
chloroquine  Prophylaxis only in areas with  300 mg base (500 mg salt) Weekly from 2 weeks prior to entry  
 chloroquine-sensitive P falciparum orally, once/week until 4 weeks after leaving (take on  
   the same day of the week)
Doxycycline  Prophylaxis in areas  100 mg orally, daily Daily from 1 day prior to entry 
Contraindicated  with chloroquine-resistant or  until 4 weeks after leaving  
in children <8  mefloquine-resistant P falciparum   
years of age and  
pregnant women
mefloquine  Prophylaxis in areas with 228 mg base (250 mg salt) Weekly from 2–7 weeks before entry  
 chloroquine-resistant P falciparum orally, once/week until 4 weeks after leaving 
    (take on the same day of the week)
Primaquine An option for prophylaxis  30 mg base (52.6 mg salt)  Daily from 1 day prior to entry until 
 in special circumstances orally, daily 7 days after leaving
taBle
Encourage  
patients to spray 
clothing with  
permethrin  
before travel.  
It remains an 
effective repellent 
even after  
multiple washes
Malaria prophylaxis
Recommendations	from	others
The World health organization (WHO) 
states that “weekly mefloquine should 
be started at least 1 week, but preferably 
2–3 weeks before departure, to achieve 
higher pre-travel blood levels and to al-
low side effects to be detected before 
travel so that possible alternatives can 
be considered.”8 
centers for Disease control and 
Prevention recommendations integrate 
recommendations from WHO and 
Cochrane.   n
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